Stock Events

Stock Events

China SXT Pharmaceuticals 

0
51
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-541.52%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
975,829.95Revenue
-5.28MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 2RY3.F. It's not an investment recommendation.
Realty Income
9
O
NVIDIA
9
NVDA
AGNC Investment
8
AGNC
Pfizer
8
PFE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
111
YI
Mkt Cap28.33M
111, Inc. operates a leading direct-to-patient digital healthcare platform in China, offering similar pharmaceutical products and services, thus competing in the same market space.
Zai Lab Limited
ZLAB
Mkt Cap2.73B
Zai Lab Limited is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines in China, directly competing in the pharmaceutical innovation and distribution sector.
HUTCHMED (China) Limited
HCM
Mkt Cap2.47B
Hutchison China MediTech Limited engages in the research, development, and commercialization of therapies in oncology and autoimmune diseases, competing for market share in China's pharmaceutical sector.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. specializes in the research, development, manufacturing, and commercialization of vaccines, competing in the healthcare and pharmaceutical market in China.
Can-Fite Biopharma
CANF
Mkt Cap4.68M
Can-Fite BioPharma Ltd. is an advanced clinical stage drug development company with a platform aimed at addressing cancer, liver, and inflammatory diseases, competing in the pharmaceutical market.
Novartis
NVS
Mkt Cap268B
Novartis AG, a multinational pharmaceutical company, offers a broad range of healthcare products that compete in the Chinese market, including innovative medicines and generics.
Pfizer
PFE
Mkt Cap158.45B
Pfizer Inc., a global biopharmaceutical company, competes in China through its wide range of healthcare products, including vaccines, oncology, and internal medicine.

About

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Show More
CEO
Feng Zhou
Employees
56
Country
Virgin Islands (British)
ISIN
VGG2161P1817
WKN
000A42QHZ

Listings

F
DE
2RY2.F
MU
DE
2RY1.MU
STU
DE
2RY1.STU
BOATS
BOATS
SXTC.BOATS

0 Comments

Share your thoughts

FAQs

What is China SXT Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange China SXT Pharmaceuticals stocks are traded under the ticker 2RY3.F.
What is China SXT Pharmaceuticals revenue for the last year?▼
China SXT Pharmaceuticals revenue for the last year amounts to 975,829.95 EUR.
What is China SXT Pharmaceuticals net income for the last year?▼
2RY3.F net income for the last year is -5.28M EUR.
How many employees does China SXT Pharmaceuticals have?▼
As of November 1, 2026, the company has 56 employees.
In which sector is China SXT Pharmaceuticals located?▼
China SXT Pharmaceuticals operates in the Health & Wellness sector.
When did China SXT Pharmaceuticals complete a stock split?▼
China SXT Pharmaceuticals has not had any recent stock splits.
Where is China SXT Pharmaceuticals headquartered?▼
China SXT Pharmaceuticals is headquartered in Taizhou, Virgin Islands (British).